Drug Information

Drug General Information
Drug ID
D04GEI
Former ID
DCL000652
Drug Name
TAK-448
Indication Prostate cancer [ICD9: 185; ICD10:C61] Phase 2 [525106]
Company
Takeda
Structure
Download
2D MOL
Target and Pathway
Target(s) Malignant melanoma metastasis-suppressor KiSS-1 Target Info Modulator
References
Ref 525106ClinicalTrials.gov (NCT02381288) Effects of TAK-448 in Middle-aged and Older Men With Low Testosterone. U.S. National Institutes of Health.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.